2-(2,6-Dioxopiperidin-3-yl)-4-fluoroisoindoline-1,3-dione>98.0%(HPLC)(T)1g

1,2-Cyclohexylenedinitrilotetraacetic acid, 95.0%, 10g

1,3-Bis-(2,4,6-trimethyl-phenyl)-4,5-dihydro-3H-imidazol-1-ium tetrafluoro borate, 95.0%, 25g

Methacryloxypropyl terminated polydimethylsiloxane, 1000 cSt, 25g

4-(Octyloxy)benzoic acid, 95.0%, 100g

3-Cyclopropylpropionic acid, 97.0%, 25g

1-(3-Methoxyphenyl)-2-thiourea, 95.0%, 250mg

(6-Methoxypyridin-3-yl)methanamine hydrochloride, 95.0%, 1g

N-(4-Hydroxyphenyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 97%, 1g

2-BROMO-5-METHYLOXAZOLE-4-CARBOXYLIC ACID, 95.0%, 1g

2-Amino-4-methyl-5-nitropyridine>98.0%(GC)(T)1g

(3R)-3-AMINO-3-(3,4-DIFLUOROPHENYL)PROPANOIC ACID, 95%, 100mg

2-Chloro-4-fluorobenzotrifluoride, 95.0%, 5g